Factor Bioscience Grows Translational Science Team, Names Kyle Garland, Ph.D., as Director of Translational Science


Factor Bioscience Grows Translational Science Team, Names Kyle Garland, Ph.D., as Director of Translational Science

Factor Bioscience Inc., a biotechnology company based in Cambridge, Massachusetts, has announced the addition of three new members to its translational science team. Led by Kyle Garland, Ph.D., who will serve as the Director of Translational Science, the team includes Associate Scientists Raven Hinkel and Elizabeth Belcher. Dr. Matt Angel, Co-Founder, Chairman, and CEO of Factor, expressed excitement about welcoming these talented scientific professionals to the team, highlighting their expertise in mRNA and cell engineering.

The new team members bring experience in various scientific fields, such as synthetic mRNA, mRNA cell reprogramming, gene editing, cell manufacturing, immunoengineering, and nucleic acid formulation. Dr. Christopher Rohde, Co-Founder and Chief Technology Officer at Factor, emphasized the diverse backgrounds and skills that the new team members bring to the company.

Dr. Garland expressed his belief in the potential of Factor’s mRNA and cell-engineering technologies to revolutionize biotechnology research and development. He looks forward to collaborating with Drs. Angel and Rohde to translate these technologies into new products. Prior to joining Factor, Dr. Garland led the Department of Research and Development at Eterna Therapeutics.

With a background in Chemical Engineering and Bioengineering from Vanderbilt University and Lehigh University, Dr. Garland brings a wealth of experience to Factor’s translational science team. Factor Bioscience focuses on developing technologies to engineer cells for improving health and quality of life. For more information about Factor Bioscience, visit their website at www.factorbio.com.

Leave a Reply